CAPTRUST Financial Advisors
TLSI icon

CAPTRUST Financial Advisors’s TriSalus Life Sciences TLSI Stock Holding History

CAPTRUST Financial Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
24,159
+2,194
+10% +$8.72K ﹤0.01% 3027
2026
Q1 		$87.9K Buy
21,965
+131
+0.6% +$641 ﹤0.01% 2829
2025
Q4 		$152K Buy
21,834
+7
+0% +$39 ﹤0.01% 2562
2025
Q3 		$101K Buy
+21,827
New +$102K ﹤0.01% 2508

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

CAPTRUST Financial Advisors's TLSI Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its TriSalus Life Sciences (TLSI) stake by 10% in Q2 2026, buying an estimated $8.72K and bringing the position to 24,159 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #3027.

CAPTRUST Financial Advisors first reported a position in TLSI in Q3 2025 and has held it in 4 quarters since. The position peaked at $152K in Q4 2025. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • CAPTRUST Financial Advisors held 24,159 shares of TriSalus Life Sciences worth $110K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 2,194 TriSalus Life Sciences shares in Q2 2026, an estimated $8.72K.
  • TriSalus Life Sciences made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3027 holding.
  • CAPTRUST Financial Advisors first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • CAPTRUST Financial Advisors's TriSalus Life Sciences position peaked at $152K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.